Adamis Pharmaceuticals is a neuro-biotechnology company developing treatments for neuro-based disorders.
Industries BiopharmaBiotechnologyMedicalTherapeuticsHeadquarters Regions Greater San Diego Area, West Coast, Western US Founded Date 2006 Founders David J Marguglio, Dennis J. Carlo Operating Status Active Last Funding Type Post-IPO Equity Also Known As ADMP Legal Name Adamis Pharmaceuticals Corp
Stock Symbol NASDAQ:ADMP Company Type For Profit
Contact Email info@adamispharma.com Phone Number +1 (858)-997-2400
Adamis Pharmaceuticals is a clinical-stage neuro-biotechnology company focused on the development and commercialization of potential blockbuster products for the treatment of a variety of neuro-based disorders with significant unmet medical needs. It commercializes products in various therapeutic areas, including allergy, opioid overdose, and
respiratory and inflammatory diseases.